Literature DB >> 18785192

The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system.

Ian M Copple1, Christopher E Goldring, Rosalind E Jenkins, Alvin J L Chia, Laura E Randle, John D Hayes, Neil R Kitteringham, B Kevin Park.   

Abstract

UNLABELLED: The transcription factor Nrf2 regulates the expression of numerous cytoprotective genes in mammalian cells. We have demonstrated previously that acetaminophen activates Nrf2 in mouse liver following administration of non-hepatotoxic and hepatotoxic doses in vivo, implying that Nrf2 may have an important role in the protection against drug-induced liver injury. Nrf2 activation has been proposed to occur through the modification of cysteine residues within Keap1, the cytosolic repressor of Nrf2. We hypothesized that acetaminophen activates Nrf2 via the formation of its reactive metabolite N-acetyl-p-benzoquinoneimine (NAPQI), which may disrupt the repression of Nrf2 through the modification of cysteine residues within Keap1. Here, we show that NAPQI can directly activate the Nrf2 pathway in mouse liver cells, inducing an adaptive defense response that is antagonized by RNA interference targeted against Nrf2. Furthermore, mass spectrometric analysis shows that NAPQI selectively modifies cysteine residues in Keap1, both in recombinant protein in vitro and in cells ectopically expressing Keap1. Using this cell-based model, we demonstrate that activation of Nrf2 by NAPQI and a panel of probe molecules [dexamethasone 21-mesylate, 15-deoxy-Delta-((12,14))-prostaglandin J(2), 2,4-dinitrochlorobenzene, and iodoacetamide] correlates with the selective modification of cysteine residues located within the intervening region of Keap1. However, substantial depletion of glutathione (to less than 15% of basal levels) by buthionine sulfoximine, which does not directly modify Keap1, is also sufficient to activate Nrf2.
CONCLUSION: Nrf2 can be activated via the direct modification of cysteine residues located within the intervening region of Keap1, but also via the substantial depletion of glutathione without the requirement for direct modification of Keap1. It is possible that both of these mechanisms contribute to the activation of Nrf2 by acetaminophen.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18785192     DOI: 10.1002/hep.22472

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  44 in total

Review 1.  Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism.

Authors:  Thomas A Baillie; Allan E Rettie
Journal:  Drug Metab Pharmacokinet       Date:  2010-10-22       Impact factor: 3.614

2.  Antioxidant fractions of Khaya grandifoliola C.DC. and Entada africana Guill. et Perr. induce nuclear translocation of Nrf2 in HC-04 cells.

Authors:  Frédéric Nico Njayou; Atsama Marie Amougou; Romeo Fouemene Tsayem; Jacqueline Njikam Manjia; Swetha Rudraiah; Bolling Bradley; José Enrique Manautou; Paul Fewou Moundipa
Journal:  Cell Stress Chaperones       Date:  2015-08-14       Impact factor: 3.667

3.  Proteomic analysis of acetaminophen-induced hepatotoxicity and identification of heme oxygenase 1 as a potential plasma biomarker of liver injury.

Authors:  Yuan Gao; Zhijun Cao; Xi Yang; Mohamed A Abdelmegeed; Jinchun Sun; Si Chen; Richard D Beger; Kelly Davis; William F Salminen; Byoung-Joon Song; Donna L Mendrick; Li-Rong Yu
Journal:  Proteomics Clin Appl       Date:  2016-10-28       Impact factor: 3.494

Review 4.  Cysteine-based regulation of the CUL3 adaptor protein Keap1.

Authors:  Konjeti R Sekhar; Girish Rachakonda; Michael L Freeman
Journal:  Toxicol Appl Pharmacol       Date:  2009-06-26       Impact factor: 4.219

Review 5.  Mechanisms of drug-induced liver injury.

Authors:  Liyun Yuan; Neil Kaplowitz
Journal:  Clin Liver Dis       Date:  2013-08-01       Impact factor: 6.126

Review 6.  Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria.

Authors:  Derick Han; Lily Dara; Sanda Win; Tin Aung Than; Liyun Yuan; Sadeea Q Abbasi; Zhang-Xu Liu; Neil Kaplowitz
Journal:  Trends Pharmacol Sci       Date:  2013-02-28       Impact factor: 14.819

7.  Differential effect of covalent protein modification and glutathione depletion on the transcriptional response of Nrf2 and NF-kappaB.

Authors:  Alvin J L Chia; Christopher E Goldring; Neil R Kitteringham; Shi Quan Wong; Paul Morgan; B Kevin Park
Journal:  Biochem Pharmacol       Date:  2010-04-21       Impact factor: 5.858

8.  Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway.

Authors:  Ian M Copple; Adam Lister; Akua D Obeng; Neil R Kitteringham; Rosalind E Jenkins; Robert Layfield; Brian J Foster; Christopher E Goldring; B Kevin Park
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

9.  Nrf2 activation protects the liver from ischemia/reperfusion injury in mice.

Authors:  Kazuhiro Kudoh; Hiroshi Uchinami; Masato Yoshioka; Ekihiro Seki; Yuzo Yamamoto
Journal:  Ann Surg       Date:  2014-07       Impact factor: 12.969

Review 10.  Current concepts of mechanisms in drug-induced hepatotoxicity.

Authors:  Stefan Russmann; Gerd A Kullak-Ublick; Ignazio Grattagliano
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.